HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Henney round two

This article was originally published in The Rose Sheet

Executive Summary

FDA Commissioner-nominee Jane Henney, MD, said she would be "committed" to meeting the May 1999 deadline for the OTC sunscreen monograph set by the FDA Modernization Act in response to Sen. Tom Harkin's (D-Iowa) follow-up questions to her Senate Labor & Human Resources confirmation hearing Sept. 2. Henney also noted the advance notice of proposed rulemaking published October 1996 on foreign marketing data's material extent/material time should be completed promptly, adding she is "willing to explore mechanisms to streamline [the data] review." Replying to Sen. Dan Coats' (R-Ind.) question on FDAMA implementation, Henney said she would ensure that FDA "has an extremely open process and that the agency actively solicits industry and public input as part of the issuance of guidance documents and regulations." Henney also clarified that "enhancing FDA's science base" means "recruiting and retaining the highest quality scientific talent available." Henney's nomination is scheduled to be taken up again Sept. 23

You may also be interested in...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts